EUNETWORKS
9.9.2021 10:02:12 CEST | Business Wire | Press release
euNetworks Group Limited (“euNetworks”), a Western European bandwidth infrastructure company, today announced that it has completed a strategic investment of critical fibre-based internet infrastructure linking London and Amsterdam, including the delivery of a new subsea high fibre count cable system named Scylla that is now in service. This is the first subsea cable system between the UK and the Netherlands since 1999.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210909005383/en/
euNetworks builds and invests in its city and long haul fibre networks to connect the key data centres and data centre hubs across the UK and Europe. The company builds Super Highways on long haul routes that are critical to Europe’s future international bandwidth needs and uses low loss fibre on these routes to deliver a low cost per bit long haul solution for its customers.
This latest state of the art, ultra high capacity fibre system extends euNetworks’ unique Super Highway network onto the Continent after delivering Super Highway 1 linking Dublin and London to Lowestoft in November 2019. euNetworks’ second Super Highway links Lowestoft via the new submarine cable Scylla to IJmuiden and then onto Amsterdam. Combined with euNetworks’ extensive metro networks in Dublin , Manchester , London and Amsterdam , the system enables any data centre to any data centre connectivity between all these metros on euNetworks’ owned and operated fibre, end-to-end.
Detailed design and permitting studies were initiated in August 2019, construction started in April 2020 and services were delivered to customers at the beginning of September 2021. This low loss network is entirely new fibre deployment. The terrestrial backhaul networks utilise new low-loss Corning SMF28 Ultra G657.A1 fibre cables and three entirely new amplification sites for the two cable landings and intermediate repeater in the UK. With existing sites and backhauls built over 20 years ago, these new facilities eliminate the unreliability of old infrastructure and provide scalable and power-efficient amplification housing, with significantly reduced long-run power demands.
Scylla itself is a non-hybrid 96 pair double-armoured sea cable, solely using Corning’s SMF28 ULL (ultra-low loss) G654.C pure silica fibre; giving all customers the benefit of future-proofed ultra-low attenuation on the 211km (cable landing station to cable landing station) unrepeatered system. This low attenuation is critical to achieving lowest cost per bit, directly driving greater bandwidth per fixed-cost transponder.
The North Sea has traditionally been a hostile environment for subsea cables, with a combination of high water current, a mobile sandy seabed and intense fishing presenting regular service challenges due to cable cuts. euNetworks planned and developed Scylla using new technology to both minimise these risks and also to lower the environmental impact from the cable laying process. During planning and mapping, the seabed was modelled to identify sand wave movement together with fishing intensity in areas with historic cable strikes. This highlighted potential areas of risk for the cable lay and subsequent path modification or planned deeper cable burial. euNetworks also used an innovative cable laying technique for telecom cables, utilising a CAPJET trenching system – a high powered water jet more commonly used for power cables – to create the 2-3 metre deep but narrow trench for the cable to lay in. The CAPJET uniquely enables greater precision and ‘micro-routing’ during the cable lay process. The remotely operated system with on-board telemetry allows for steering in real-time. The low ploughing tension allows for quick manoeuvrability, delivering a finer cable lay plan, burial between the troughs in natural sand formations and subsequent deeper burying of the cable over time. This contrasts with a traditional ploughed burial, which may achieve theoretically similar depths, but must follow much straighter paths over sand waves with amplitudes of 8m and pitches of 12o . Such an approach creates risks to the initial lay, uneven burial depth and still leaves the probability of the cable becoming unburied over time. As well as ensuring deeper burial naturally, laying the cable with precision and less impact on the seabed, euNetworks has buried Scylla up to 3 metres deep versus typical 0.7 metres for existing systems, offering better protection against strikes both today and in the future.
On land the company has also designed and planned this new network with sustainability in mind. The route is designed with optimal spacing and attenuation loss between amplifier sites, meaning less ILA/PoP sites compared to other routes in service. The use of modern fibre types plus a reduction in ILA sites along the route meant less construction during deployment, less resources and less power consumption in service. In addition, the technology used within the new ILA sites is new, with more efficient air conditioning monitoring the air being drawn in and hence using less power when cooling. Overall this approach delivers a much lower power consumption per bit and delivers an optimised low carbon footprint network infrastructure.
“This Super Highway is an important investment in Western European bandwidth infrastructure,” said Brady Rafuse, Chief Executive Officer of euNetworks. “We’ve delivered the first new subsea cable on this important route in 20 years and delivered a unique route running between London and Amsterdam to support the many businesses whose connectivity requirements continue to grow. Critically for our customers, this network development continues our approach of delivering highly scalable, owned and operated fibre based sustainable infrastructure to support their needs.”
“We extend our thanks to all those who have worked with us on this project. We look forward to continuing to work closely with our customers in these regions and across our networks, delivering the bandwidth experience and scale they need,” said Rafuse.
About euNetworks
euNetworks is a bandwidth infrastructure company, owning and operating 17 fibre based metropolitan networks connected with a high capacity intercity backbone covering 51 cities in 15 countries across Europe. The company leads the market in data centre connectivity, directly connecting over 450 today. euNetworks is also a leading cloud connectivity provider and offers a targeted portfolio of metropolitan and long haul services including Dark Fibre, Wavelengths, and Ethernet. Wholesale, finance, content, media, mobile, data centre and enterprise customers benefit from euNetworks’ unique inventory of fibre and duct based assets that are tailored to fulfil their high bandwidth needs. For further information visit eunetworks.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210909005383/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release
- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release
New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release
Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea
Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release
Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
